Lifestyle Changes Through Exercise and Nutrition (LEAN)
The Lifestyle Changes Through Exercise and Nutrition (LEAN) Project
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Louisiana
-
Baton Rouge, Louisiana, Stati Uniti, 70808
- Pennington Biomedical Research Center
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- self-identify as African American
- a member of a participating church
- age 18-75 years old
- BMI > 30
- own a mobile phone with text message capabilities
- at risk for diabetes (diagnosed nuclear family member or gestational diabetes) or diagnosed with type 2 diabetes
- willing to provide written informed consent
- willing to change diet, physical activity and weight
- able to participate in face-face counselling sessions as scheduled
- low to moderate cardiovascular disease risk
Exclusion Criteria:
- currently participating in a weight loss program
- currently using weight loss medication or have lost weight (>10 lbs in last year)
- planning to move from the area within the next year
- given birth within the past year, are currently pregnant or plan to become pregnant within the next year
- planning to have bariatric surgery within 2 years
- history of major depression, suicidal behavior or eating disorder
- hospitalization for a mental disorder or substance abuse in the last year
- have cancer or had cancer within the past 5 years.
- serious heart problems such as arrhythmias, cardiomyopathy, congestive heart failure
- stroke or heart attack in the last six months
- high blood pressure [systolic ≥160, or diastolic ≥100]
- chronic inflammatory conditions, including but not limited to severe arthritis, lupus, or inflammatory bowel disease
- diseases that are life threatening or that can interfere with or be aggravated by exercise or weight loss
- unwilling or unable to provide informed consent
- physician's or principal investigator's decision to exclude
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione incrociata
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Weight loss intervention
Churches randomized to the intervention condition will receive the community health coach delivered church based intervention for 6 months followed by 6 months of weight maintenance.
|
The intervention will involve utilizing trained community health coaches to deliver the weight loss intervention.
There will be 10 group based sessions conducted at each church over 6 months.
Session frequency will be 4 weekly sessions (4) for the first month, bimonthly sessions for 2 months (4) and monthly sessions for 2 months (2).
The study is based upon weight loss strategies that have been utilized in the Diabetes Prevention Program.
The group sessions will be augmented by utilizing text messages.
The text messages will be delivered weekly and three types of messages will be delivered: 1) lesson content, 2) motivational, 3) behavioral prompts.
|
|
Sperimentale: Delayed Treatment Control Group
Churches in the delayed treatment control condition will receive information on various health topics relevant to African Americans, such as strokes, lupus, sickle cell, etc. via text message during the first six months.
Participants in this group will not receive any behavioral strategies designed to alter weight, physical activity, or diet during this time.
They will receive the community health coach delivered church based weight loss intervention after 6 months.
|
The intervention will involve utilizing trained community health coaches to deliver the weight loss intervention.
There will be 10 group based sessions conducted at each church over 6 months.
Session frequency will be 4 weekly sessions (4) for the first month, bimonthly sessions for 2 months (4) and monthly sessions for 2 months (2).
The study is based upon weight loss strategies that have been utilized in the Diabetes Prevention Program.
The group sessions will be augmented by utilizing text messages.
The text messages will be delivered weekly and three types of messages will be delivered: 1) lesson content, 2) motivational, 3) behavioral prompts.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Percent weight loss
Lasso di tempo: Month 6 and Year 1
|
Percent weight loss will be calculated at 6 and 12 months.
|
Month 6 and Year 1
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Body Fat Percentage
Lasso di tempo: Screening, Month 6 and Year 1
|
The participant's body fat percentage is measured using the portable Tanita Body Composition Analyzer (SC-240).
|
Screening, Month 6 and Year 1
|
|
Change in Blood Glucose
Lasso di tempo: Screening, Month 6 and Year 1
|
The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible glucose testing results.
The Cholestech uses fingerstick sampling and small sample size (40μL) that makes results less time consuming and easy to obtain.
|
Screening, Month 6 and Year 1
|
|
Change in Blood Pressure
Lasso di tempo: Screening, Month 6 and Year 1
|
Blood pressure will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar).
Participants will rest for approximately 5 minutes prior to blood pressure measurement to ensure accurate at rest reading.
|
Screening, Month 6 and Year 1
|
|
Change in Food Intake
Lasso di tempo: Screening, Month 6 and Year 1
|
The National Cancer Institute (NCI) fat screener estimates the percentage of energy from fat by asking patients to report the frequency of consuming specific foods over the past 12 months.
A standard 7-item fruit and vegetable screener developed by the NCI and National 5 a Day Program grantees asks how often fruit and vegetables were consumed in the past month.
|
Screening, Month 6 and Year 1
|
|
Change in Physical activity
Lasso di tempo: Screening, Month 6 and Year 1
|
The International Physical Activity Questionnaire (IPAQ) questionnaire is a self-report measure of physical activity.
The metabolic equivalent task (MET) minutes in each domain of leisure time activity, that is, sedentary, light, moderate, and vigorous intensity, will be calculated.
The IPAQ has been shown to be a reliable and valid measure of physical activity and has been sensitive to changes in physical activity resulting from intervention programs.
|
Screening, Month 6 and Year 1
|
|
Change in Quality of Life
Lasso di tempo: Screening, Month 6 and Year 1
|
. Each participant's quality of life will be assessed using the Impact of Weight on Quality of Life Survey.
|
Screening, Month 6 and Year 1
|
|
Satisfaction Questionnaire
Lasso di tempo: Month 6 and Year 1
|
Each participant's satisfaction with the different elements of the study, including the community health coaches, the intervention, and the text messages, will be measured using a questionnaire developed by the investigators.
|
Month 6 and Year 1
|
|
Change in Blood Cholesterol
Lasso di tempo: Screening, Month 6 and Year 1
|
The Alere Cholestech LDX® Analyzer is engineered to provide accurate, actionable, and readily accessible cholesterol testing results.
The Cholestech uses fingerstick sampling and small sample size (40μL) that makes results less time consuming and easy to obtain.
|
Screening, Month 6 and Year 1
|
|
Change in Pulse
Lasso di tempo: Screening, Month 6 and Year 1
|
Pulse will be measured using an automatic blood pressure cuff (Omeron, Model BP710 or similar).
Participants will rest for approximately 5 minutes prior to pulse measurement to ensure accurate at rest reading.
|
Screening, Month 6 and Year 1
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: Robert L Newton, Jr., PhD, Pennington Biomedical Research Center
Pubblicazioni e link utili
Pubblicazioni generali
- Nguyen T, Irwin ML, Dewan AT, Cartmel B, Harrigan M, Ferrucci LM, Sanft T, Li F, Lu L, Salinas YD. Examining the effect of obesity-associated gene variants on breast cancer survivors in a randomized weight loss intervention. Breast Cancer Res Treat. 2021 Jun;187(2):487-497. doi: 10.1007/s10549-021-06151-5. Epub 2021 Mar 6.
- Newton RL Jr, Carter LA, Johnson W, Zhang D, Larrivee S, Kennedy BM, Harris M, Hsia DS. A Church-Based Weight Loss Intervention in African American Adults using Text Messages (LEAN Study): Cluster Randomized Controlled Trial. J Med Internet Res. 2018 Aug 24;20(8):e256. doi: 10.2196/jmir.9816.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- PBRC 2016-018
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .